crane co - CR
CR
Close Chg Chg %
187.75 8.48 4.52%
Closed Market
196.23
+8.48 (4.52%)
Volume: 725.12K
Last Updated:
Feb 6, 2026, 3:59 PM EDT
Company Overview: crane co - CR
CR Key Data
| Open $192.00 | Day Range 190.53 - 197.00 |
| 52 Week Range 127.04 - 214.31 | Market Cap $10.93B |
| Shares Outstanding 57.60M | Public Float 57.00M |
| Beta 1.25 | Rev. Per Employee N/A |
| P/E Ratio 30.00 | EPS $5.62 |
| Yield 48.99% | Dividend $0.26 |
| EX-DIVIDEND DATE Feb 27, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 537.70K |
CR Performance
| 1 Week | 2.81% | ||
| 1 Month | -7.30% | ||
| 3 Months | -0.88% | ||
| 1 Year | 9.08% | ||
| 5 Years | N/A |
CR Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
12
Full Ratings ➔
About crane co - CR
Crane Co. designs and manufactures aerospace, electronics & engineered industrial products. It operates through four segments: Aerospace & Electronics, Process Flow Technologies, Payment & Merchandising Technology, and Engineered Materials. The company was founded by Richard Teller Crane on July 4, 1855 and is headquartered in Stamford, CT.
CR At a Glance
Crane Co.
100 First Stamford Place
Stamford, Connecticut 06902
| Phone | 1-203-363-7300 | Revenue | 2.31B | |
| Industry | Aerospace & Defense | Net Income | 366.60M | |
| Sector | Electronic Technology | 2025 Sales Growth | 8.155% | |
| Fiscal Year-end | 12 / 2026 | Employees | N/A | |
| View SEC Filings |
CR Valuation
| P/E Current | 29.997 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 29.462 |
| Price to Sales Ratio | 4.689 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | 27.37 |
| Enterprise Value to EBITDA | 21.556 |
| Enterprise Value to Sales | 4.436 |
| Total Debt to Enterprise Value | 0.112 |
CR Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | N/A |
| Receivables Turnover | 6.426 |
| Total Asset Turnover | 0.71 |
CR Liquidity
| Current Ratio | 5.528 |
| Quick Ratio | 4.718 |
| Cash Ratio | 3.718 |
CR Profitability
| Gross Margin | 42.204 |
| Operating Margin | 18.403 |
| Pretax Margin | 18.777 |
| Net Margin | 15.905 |
| Return on Assets | 10.214 |
| Return on Equity | 17.92 |
| Return on Total Capital | 10.328 |
| Return on Invested Capital | 12.865 |
CR Capital Structure
| Total Debt to Total Equity | 55.646 |
| Total Debt to Total Capital | 35.752 |
| Total Debt to Total Assets | 29.797 |
| Long-Term Debt to Equity | 55.646 |
| Long-Term Debt to Total Capital | 35.752 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Crane Co - CR
Collapse All in section
| All values USD millions. | 2022 | 2023 | 2024 | 2025 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 2.04B | 2.09B | 2.13B | 2.31B | |
Sales Growth
| -36.01% | +2.53% | +2.15% | +8.16% | |
Cost of Goods Sold (COGS) incl D&A
| 1.32B | 1.28B | 1.26B | 1.33B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 39.60M | 39.30M | 51.00M | 50.20M | |
Depreciation
| 33.90M | 33.00M | 33.40M | 36.40M | |
Amortization of Intangibles
| 5.70M | 6.30M | 17.60M | 13.80M | |
COGS Growth
| -31.85% | -3.03% | -1.40% | +5.45% | |
Gross Income
| 713.60M | 805.00M | 867.80M | 972.80M | |
Gross Income Growth
| -42.50% | +12.81% | +7.80% | +12.10% | |
Gross Profit Margin
| +35.07% | +38.58% | +40.72% | +42.20% |
| 2022 | 2023 | 2024 | 2025 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 478.80M | 521.20M | 512.00M | 548.60M | |
Research & Development
| - | 49.20M | 55.90M | 46.10M | |
Other SG&A
| 429.60M | 465.30M | 465.90M | 548.60M | |
SGA Growth
| -36.63% | +8.86% | -1.77% | +7.15% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | - | - | 4.20M | - |
EBIT after Unusual Expense
| 230.60M | 283.80M | 355.80M | 424.20M | |
Non Operating Income/Expense
| 94.30M | 5.90M | 9.90M | 19.90M | |
Non-Operating Interest Income
| 17.60M | 5.10M | 5.50M | 11.20M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 10.30M | 22.70M | 27.20M | 11.30M | |
Interest Expense Growth
| -78.04% | +120.39% | +19.82% | -58.46% | |
Gross Interest Expense
| 10.30M | 22.70M | 27.20M | 11.30M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 314.60M | 267.00M | 338.50M | 432.80M | |
Pretax Income Growth
| -34.07% | -15.13% | +26.78% | +27.86% | |
Pretax Margin
| +15.46% | +12.80% | +15.88% | +18.78% | |
Income Tax
| 114.80M | 63.20M | 70.30M | 101.10M | |
Income Tax - Current - Domestic
| - | 23.50M | 48.60M | 43.70M | |
Income Tax - Current - Foreign
| - | 75.70M | 36.10M | 38.20M | |
Income Tax - Deferred - Domestic
| - | 16.40M | (17.30M) | (9.10M) | |
Income Tax - Deferred - Foreign
| - | (800.00K) | (4.20M) | (2.50M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 199.80M | 203.80M | 268.20M | 331.70M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 199.80M | 203.80M | 268.20M | 331.70M | |
Net Income Growth
| -49.33% | +2.00% | +31.60% | +23.68% | |
Net Margin Growth
| +9.82% | +9.77% | +12.58% | +14.39% | |
Extraordinaries & Discontinued Operations
| - | 52.10M | 26.50M | 34.90M | |
Discontinued Operations
| - | 52.10M | 26.50M | 34.90M | |
Net Income After Extraordinaries
| 199.80M | 255.90M | 294.70M | 366.60M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 199.80M | 255.90M | 294.70M | 366.60M | |
EPS (Basic)
| 3.5222 | 4.5132 | 5.1521 | 6.3756 | |
EPS (Basic) Growth
| -52.76% | +28.14% | +14.16% | +23.75% | |
Basic Shares Outstanding
| 56.73M | 56.70M | 57.20M | 57.50M | |
EPS (Diluted)
| 3.5222 | 4.4504 | 5.0549 | 6.26 | |
EPS (Diluted) Growth
| -52.11% | +26.35% | +13.58% | +23.84% | |
Diluted Shares Outstanding
| 56.73M | 57.50M | 58.30M | 58.60M | |
EBITDA
| 274.40M | 323.10M | 406.80M | 474.40M | |
EBITDA Growth
| -54.64% | +17.75% | +25.91% | +16.62% | |
EBITDA Margin
| +13.48% | +15.49% | +19.09% | +20.58% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 223.875 | |
| Number of Ratings | 12 | Current Quarters Estimate | 1.444 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 6.679 | |
| Last Quarter’s Earnings | 1.53 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 6.05 | Next Fiscal Year Estimate | 7.545 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 6 | 6 | 8 | 8 |
| Mean Estimate | 1.44 | 1.58 | 6.68 | 7.55 |
| High Estimates | 1.46 | 1.60 | 6.70 | 7.84 |
| Low Estimate | 1.39 | 1.55 | 6.62 | 7.25 |
| Coefficient of Variance | 1.87 | 1.32 | 0.42 | 2.25 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 7 | 7 | 6 |
| OVERWEIGHT | 2 | 2 | 3 |
| HOLD | 2 | 2 | 2 |
| UNDERWEIGHT | 1 | 1 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Crane Co - CR
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Crane Co - CR
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| May 2, 2025 | James Luther Lyman Tullis Director | 32,322 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Susan Diane Lynch Director | 1,723 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Susan Diane Lynch Director | 1,720 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Sanjay Kapoor Director | 6,514 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Sanjay Kapoor Director | 6,541 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Ellen McClain Haime Director | 23,897 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Ellen McClain Haime Director | 23,782 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Martin R. Benante Director | 19,120 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Martin R. Benante Director | 19,028 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Martin R. Benante Director | 1,776 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Charles G. McClure Director | 18,056 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | James Luther Lyman Tullis Director | 32,161 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Ronald Carter Lindsay Director | 27,638 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Ronald Carter Lindsay Director | 27,504 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Jennifer M. Pollino Director | 22,997 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Jennifer M. Pollino Director | 22,886 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 2, 2025 | Charles G. McClure Director | 18,143 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 17, 2025 | Marijane Papanikolaou V.P., Controller & CAO | 2,114 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 17, 2025 | Max Homer Mitchell Chairman, President and CEO; Director | 21,097 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 17, 2025 | Max Homer Mitchell Chairman, President and CEO; Director | 391,351 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $172 per share | 67,312,372.00 |